Reply
Damiano Patrono, Eloisa Franchi, Francesco Lupo, Renato Romagnoli – 26 March 2020
Spotlight on Impactful Research: Utilization of Aspirin and Statin in Management of Coronary Artery Disease in Patients With Cirrhosis Undergoing Liver Transplant Evaluation
Leana Frankul, Catherine T. Frenette – 26 March 2020
Checkpoint Inhibitors for the Treatment of Advanced Hepatocellular Carcinoma
Laura A. Huppert, John D. Gordan, Robin Kate Kelley – 26 March 2020
Checkpoint Inhibitors for the Treatment of Advanced Hepatocellular Carcinoma
Laura A. Huppert, John D. Gordan, Robin Kate Kelley – 26 March 2020
Living Donor Liver Transplantation When Deceased Donor Is Not Possible or Timely: Case Examples and Ethical Perspectives
Alexandra Shingina, Martin Montenovo – 25 March 2020
Vascular Remodeling of Visceral Arteries Following Interruption of the Splenic Artery During Liver Transplantation
Salvatore Gruttadauria, Duilio Pagano, Settimo Caruso, Davide Cintorino – 25 March 2020
Reply
Gastón J. Piñeiro, Jordi Rovira, Fritz Diekmann, Nuria Esforzado – 25 March 2020
Validation of PAS Kinase, a Regulator of Hepatic Fatty Acid and Triglyceride Synthesis, as a Therapeutic Target for Nonalcoholic Steatohepatitis
Wojciech Swiatek, K. Mark Parnell, G. Allen Nickols, Bruce F. Scharschmidt, Jared Rutter – 24 March 2020 – Hyperactivation of sterol regulatory element binding protein 1c (SREBP‐1c), which transcriptionally induces expression of enzymes responsible for de novo lipogenesis and triglyceride (TG) formation, is implicated in nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) pathogenesis. Posttranslational SREBP‐1c maturation and activation is stimulated by the protein per–arnt–sim kinase (PASK).
Cover Image
22 March 2020
Hepatology Highlights
Nidhi Jalan‐Sakrikar, Robert E. Schwartz, Muhammad Amir, Joel Wedd, Joseph F. Pisa, Robert S. Brown, Nicholas W. Russo, Ravi S. Vora, Alyson Kaplan, Russell Rosenblatt, Amaia Navarro‐Corcuera, Enis Kostallari, Petra Hirsova – 22 March 2020